Quantcast

Latest Tuberculosis treatment Stories

2009-01-06 11:33:23

Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. But the investigators highlight the proven superiority of the six-week regimen in preventing mother-to-child HIV transmission in breast-fed infants.In a study led by researchers at Johns Hopkins Children's Center, risks of drug...

124848d9ee290b613437adba8783981e
2008-11-06 14:07:24

New research on drug-resistant tuberculosis found that the hard-to-treat disease results in death for half of patients who get it. South Korean researchers presented the study "“ one of few to track survival rates from the condition called extensively drug-resistant TB "“ in the latest edition of the American Journal of Respiratory and Critical Care Medicine. The study consisted of 1,407 patients who had either multidrug resistant TB, which is the most aggressive because it...

2008-10-30 06:00:44

Concert Pharmaceuticals, a biotechnology company, has announced encouraging findings from a preclinical study suggesting that C-20081, a novel, deuterium-containing oxazolidinone antibiotic, may be suitable for once-daily oral and intravenous dosing. In the preclinical study, C-20081 had a 43% increase in plasma half-life compared to linezolid, which might allow for lower overall drug exposure and improved tolerability with a once-daily dose. Concert has evaluated the effect of selective...

2008-10-27 09:00:12

SAN FRANCISCO, Oct. 27 /PRNewswire/ -- 5:00 AM PST -- UCB announced today results from several Phase III clinical trials evaluating CIMZIA(R) (certolizumab pegol) - the only PEGylated anti-TNF (Tumor Necrosis Factor) - presented at the American College of Rheumatology (ACR) Annual Scientific Meeting. Results from the open-label extension study to RAPID 1 met both co-primary endpoints (American College of Rheumatology (ACR) 20 response(a) scores at Week 24 and change from baseline in modified...

2008-10-16 12:00:25

Genzyme, a biotechnology company, has started enrollment in a world-wide post-marketing clinical trial evaluating the efficacy and safety of treating pediatric male patients with mild Fabry disease symptoms with a low-dose regimen of Fabrazyme. Approximately 20 institutions across Europe, the US, Canada and Latin America are expected to participate in the study. The trial will examine the efficacy and safety of two lower-dose regimens of Fabrazyme in male patients aged five to 18 years over...

2008-10-06 09:00:09

ORLANDO, Fla., Oct. 6 /PRNewswire/ -- UCB today presented data from a large, prospective study investigating endoscopic improvement in Crohn's disease (CD) with a biologic compound. The data presented at the American College of Gastroenterology Annual Scientific Meeting demonstrates that CIMZIA(R) (certolizumab pegol) -- the only PEGylated anti-TNF alpha (Tumor Necrosis Factor alpha) -- significantly improved endoscopic lesions and induced endoscopic response (as assessed by the Crohn's...

2008-10-03 00:00:06

U.S. researchers have determined that Mycobacterium tuberculosis has learned through evolution to coat itself with a sugar called mannose. This sugar makes the bacterium attractive to cells in the lungs that are looking to clean up and discard unwanted sugar in the body. Those lung cells absorb the TB bacteria, giving the infecting bacteria a place to live for the long term, Ohio State University researchers said. "The bug sugarcoats itself and creates this magical interaction that allows...

2008-09-27 03:00:33

By John Canalis LONG BEACH - A single case of tuberculosis has been confirmed at Wilson High School, city health officials said Friday. Authorities would not identify the victim or say if the infected party was a student, teacher, staff member or volunteer. "One individual has active tuberculous," said Dr. Helene Calvet, city health officer. A number of students and staff "may have had significant exposure," to the infected party, according to a statement from the Long Beach...

2008-09-26 15:00:14

By HILL, Ruth HEALTH officials have broadened their search for people who may have been infected by a rare, aggressive form of tuberculosis that killed an Auckland woman before it was diagnosed. Auckland District Health Board began tests this week on about 240 staff and up to 20 patients who came into contact with the woman during her several-week stay in Auckland City Hospital. Chief medical officer David Sage said the board was still tracking patients who were in hospital at the...

2008-09-26 00:00:31

Health officials in New Zealand are looking for anyone who may have been exposed to a woman with an aggressive form of tuberculosis. The Auckland District Health Board said it was testing 240 staff members and up to 20 patients who came into contact with the woman while she was at Auckland City Hospital, the Dominion Post reported Thursday. Lab tests have only recently confirmed that the woman, who died several weeks ago, had a rare form of TB, the newspaper said.


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related